News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • American Resources reports incremental operational progress at its ReElement rare‑earth unit.
  • Market capitalization remains below $250 million.
  • Production metrics are improving.
  • Company completed recent financing that increases cash and flexibility.
  • Analyst maintains Buy rating and recommends buying on strength, adding on dips.
  • Recommended entry around current levels with a tight stop under prior support.
  • Targeting a mid‑single‑digit stock re‑rate within 45 trading days if execution continues.

Latest Articles

Trekor Announces 36 Million Pounds of Copper Production from Gibraltar and Florence Copper in the Second Quarter

Trekor Announces 36 Million Pounds of Copper Production from Gibraltar and Florence Copper in the Second Quarter

Trekor Metals Limited announced its second quarter production results from its Gibraltar and Florence Copper assets. Gibraltar mine produced 30.3 million pounds of copper and 559 thousand pounds of molybdenum, maintaining consistent operations, while Florence Copper ramped up production smoothly with 5.2 million pounds of copper cathode produced. T…

Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD

Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD

Supernus Pharmaceuticals celebrates the 5-year anniversary of FDA approval of Qelbree, a novel non-stimulant ADHD medication approved for children and adults. Qelbree has filled approximately 3 million prescriptions since launch and offers a unique pharmacodynamic profile targeting norepinephrine and serotonin receptors. The drug's safety, efficacy…

Cycurion CEO Kevin Kelly Details Expansion Strategy, New Revenue Streams and Aggressive Response to Market Abuse in Candid Shareholder Video

Cycurion CEO Kevin Kelly Details Expansion Strategy, New Revenue Streams and Aggressive Response to Market Abuse in Candid Shareholder Video

Cycurion, Inc., a Nasdaq-listed cybersecurity company, announced operational growth, strategic acquisitions, expanding higher-margin product offerings, and efforts to address suspected market manipulation. CEO Kevin Kelly emphasized the company's focus on scalable growth, improving profitability, and creating shareholder value while targeting under…

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

SS Innovations International, a developer of surgical robotic technologies, has appointed Sarah M. Romano as Chief Financial Officer effective August 3, 2026. Ms. Romano brings over two decades of financial leadership experience in the medical technology and life sciences sectors and will support SS Innovations' global expansion, including pursuing…

InterDigital Announces Date for Second Quarter 2026 Financial Results

InterDigital Announces Date for Second Quarter 2026 Financial Results

InterDigital, Inc., a leader in wireless, video, and AI technology development, announced the release date for its second quarter 2026 financial results, scheduled for July 30, 2026, before market open. A conference call with company executives will follow to discuss performance. The company continues to license its innovations worldwide across wir…

Applied Optoelectronics: Selloff Looks Scary, But I’m Adding Here

Applied Optoelectronics: Selloff Looks Scary, But I’m Adding Here

Applied Optoelectronics (AAOI) has seen an epic run in 2026 and a recent cool-off that brought momentum indicators into bearish territory. The selloff stings, but the company's position as a supplier of optical transceivers for AI datacenters, clean balance sheet metrics, and still-robust demand give me confidence to buy a tactical long with define…

Workday Shares Plunge After IBM’s Weak Q2 Preview and Rising Insider Sales

Workday Shares Plunge After IBM’s Weak Q2 Preview and Rising Insider Sales

Workday stock dropped sharply in pre-market trade following a surprise preliminary earnings update from IBM that fell short of expectations. IBM reported $17.2 billion in revenue for the quarter, a 1% increase year over year, and said clients are reallocating capital expenditures toward hardware - a development that could siphon discretionary IT do…

U.S. Consumer Inflation Sees Sharp Monthly Drop in June, Led by Lower Gas Prices

U.S. Consumer Inflation Sees Sharp Monthly Drop in June, Led by Lower Gas Prices

Headline U.S. consumer inflation fell 0.4% month-on-month in June, the biggest single-month decline since April 2020, driven in part by lower gasoline prices. Core CPI, which excludes food and energy, was unchanged in June after a 0.2% increase in May. On a year-over-year basis, headline CPI rose 3.5% and core CPI increased 2.6%, both softer than e…

Rackspace Technology Recognized as a Leader in Two Categories of 2026 ISG Provider Lens®, Private/Hybrid Cloud

Rackspace Technology Recognized as a Leader in Two Categories of 2026 ISG Provider Lens®, Private/Hybrid Cloud

Rackspace Technology was recognized as a leader in two categories in the 2026 ISG Provider Lens Private/Hybrid Cloud Data Center Services Report for the U.S. and U.K., emphasizing its AI-ready infrastructure managed services and resilient hybrid cloud solutions. The recognition underscores Rackspace's capability in supporting enterprises—especially…

BofA Sees Opportunity in European Software Ahead of Q2 Results

BofA Sees Opportunity in European Software Ahead of Q2 Results

Bank of America has turned constructive on the European software sector ahead of second-quarter earnings, arguing that the sector's steep underperformance year-to-date creates an appealing risk-reward profile. The brokerage expects software revenue growth of 9.4% for the quarter and reiterated buy recommendations on SAP, Sage, Planisware and Temeno…

Citi Posts 45% Rise in Quarterly Profit as Trading and Deal Fees Surge

Citi Posts 45% Rise in Quarterly Profit as Trading and Deal Fees Surge

Citigroup reported a 45% increase in second-quarter net income and recorded its strongest quarterly revenue in ten years, driven by a spike in trading revenue amid market volatility and a jump in investment banking fees. The bank posted $5.8 billion in net income on $24.8 billion in revenue, with notable gains across equities trading, investment ba…

Analyst Upgrades Drive Texas Instruments Stock Higher Ahead of Q2 Report

Analyst Upgrades Drive Texas Instruments Stock Higher Ahead of Q2 Report

Texas Instruments shares climbed in pre-market activity after KeyBanc raised its price target to $390 from $325 and kept an Overweight rating, while Citi reiterated its Buy stance with a $345 target. The analyst moves come as the company approaches its Q2 2026 earnings report on July 22, with consensus estimates pointing to roughly $1.90 in EPS and…

Kratos Gains After $400M Department of Defense Funding Boost

Kratos Gains After $400M Department of Defense Funding Boost

Kratos Defense & Security Solutions said it received about $400 million in new Department of Defense funding tied to hypersonic system programs and other national security initiatives. The company said the funds began flowing in June and accelerated in July, and management expects the award to lift organic growth, increase operating cash receipts a…

Virtu Announces Preliminary Estimated Second Quarter 2026 Results and Commences Marketing of Incremental First Lien Term Loan

Virtu Announces Preliminary Estimated Second Quarter 2026 Results and Commences Marketing of Incremental First Lien Term Loan

Virtu Financial, a leading global market maker and financial technology provider, announced preliminary estimated results for Q2 2026, showing net income of $285 million and normalized adjusted EPS of $1.82. The company is also commencing marketing for an incremental $400 million first lien term loan, increasing its total term loan balance. Final Q…

Bank of America Posts Strong Quarter but Shares Slip in Pre-Market Trading

Bank of America Posts Strong Quarter but Shares Slip in Pre-Market Trading

Bank of America reported a robust Q2 2026 with net income and revenue comfortably ahead of analyst expectations, driven by record sales and trading and a rebound in investment banking fees. Despite the beats, BAC shares fell modestly in pre-open trading as the stock’s run-up left limited upside and broader market weakness prompted risk-off position…

VisionWave Files U.S. Provisional Patent Application for SkyWeave™, an AI-Orchestrated Satellite-Free Global Communication Ecosystem

VisionWave Files U.S. Provisional Patent Application for SkyWeave™, an AI-Orchestrated Satellite-Free Global Communication Ecosystem

VisionWave Holdings filed a U.S. provisional patent application for SkyWeave™, an AI-orchestrated high-frequency communication ecosystem designed to enable resilient, long-range communication in environments where satellite and traditional infrastructure are unavailable or compromised. This technology targets defense, autonomous systems, emergency …

AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding

AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding

AEON Biopharma announced a priced public offering of approximately $13.75 million through the issuance of common stock and pre-funded warrants, accompanied by milestone warrants that could provide an additional $29.6 million in future funding. The capital will be used to support ABP-450, their biosimilar to BOTOX for therapeutic use, focusing on an…